Slideshow

Efficacy Vs Tolerability in Bipolar Depression

Author(s):

James Phelps, MD

Which is more important, for whom?

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!
Related Videos
medication switching bipolar disorder
lithium
Related Content
IV ketamine NRX-100
August 28th 2025

New Expanded Access Policy for NRX-100 for Suicidal Ideation

Jessica Walters
Blue Light, Depression, and Bipolar Disorder
August 28th 2025

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP
database igalmi BXCL501
August 28th 2025

Database Lock in Trial for New At-Home Treatment of Agitation in Bipolar Disorders and Schizophrenia

Jessica Walters
Four Myths About Lamotrigine
August 28th 2025

Four Myths About Lamotrigine

Chris Aiken, MD Kellie Newsome, PMH-NP
bipolar
August 28th 2025

BXCL501 for Agitation Associated With Bipolar Disorders or Schizophrenia: Positive Pre-sNDA Meeting With FDA

Leah Kuntz
depression
August 28th 2025

FDA Grants Fast Track Designation for NRX-100 for Suicidal Ideation in Patients With Depression, Including Bipolar Depression

Leah Kuntz
© 2025 MJH Life Sciences

All rights reserved.